Westin, J., Chavez, J., Schuster, S. J., Vucinic, V., Young, P. A., Johnson, P. C., Bramanti, S., Rambaldi, A., Meijide, J. B., Kato, K., Sancho, J., Kwon, M., Solano, C., Fleming, S., Dahiya, S., Garcia-Sancho, A. M., Ramos, P. M., Pearson, D., Diallo, S., Zia, A., Segura, E., Masood, A., Barba, P. (2025). Rapcabtagene autoleucel (YTB323) for patients with first line high-risk large B-cell lymphoma: Phase II interim results. Blood. https://doi.org/10.1182/blood-2025-670